Emergent BioSolutions
Emergent BioSolutions Inc.
400 Professional Drive, Suite 400
Gaithersburg, MD 20879
Phone: (240) 631 3200Website: https://www.emergentbiosolutions.com/Careers: www.emergentbiosolutions.com/careers
Latest news
- Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication
29 August 2024 - FDA Approves Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
20 July 2023 - Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
24 June 2023 - NaxSwab OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone from an opioid overdose in study
13 April 2023 - FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ Narcan Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
29 March 2023 - New Drug Application for RiVive Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA
26 December 2022 - Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter Narcan (naloxone HCl) Nasal Spray
6 December 2022 - Emergent BioSolutions Announces Exercise by BARDA of the First Contract Option, Valued at $261 Million, to Procure Doses of AV7909 Anthrax Vaccine Candidate for the Strategic National Stockpile
30 July 2019 - Emergent BioSolutions Prepares for Initial Shipments of AV7909 Anthrax Vaccine Candidate into the Strategic National Stockpile
15 May 2019 - Emergent BioSolutions Initiates Phase 3 Clinical Study to Evaluate AV7909 for Post-Exposure Prophylaxis of Anthrax
19 March 2019
Drugs Associated with Emergent BioSolutions Inc.
Emergent BioSolutions Inc. manufactures, markets and/or distributes more than 10 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
ACAM2000
Generic name: smallpox vaccine Drug class: viral vaccines |
||
|
Anthrasil
Generic name: anthrax immune globulin intravenous |
||
|
BAT
Generic name: botulism antitoxin Drug class: antitoxins and antivenins |
||
|
Biothrax
Generic name: anthrax vaccine adsorbed Drug class: bacterial vaccines |
||
|
Cyfendus
Generic name: anthrax vaccine adsorbed Drug class: bacterial vaccines |
||
|
Narcan
Generic name: naloxone Drug class: antidotes |
5 reviews | 8.2 / 10 |
|
raxibacumab
Generic |
||
|
Tembexa
Generic name: brincidofovir Drug class: purine nucleosides |
||
|
Vaxchora
Generic name: cholera vaccine, live Drug class: bacterial vaccines |
||
|
Vivotif
Generic name: typhoid vaccine, live Drug class: bacterial vaccines |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||